Novavax, Inc. (LON:0A3S)
London flag London · Delayed Price · Currency is GBP · Price in USD
6.42
-0.06 (-0.93%)
At close: Jun 27, 2025

Novavax Market Cap

Novavax has a market cap or net worth of 752.34 million as of June 30, 2025. Its market cap has decreased by -59.24% in one year.

Market Cap
752.34M
Enterprise Value
385.69M
Revenue
971.33M
Ranking
n/a
PE Ratio
2.03
Stock Price
6.42

Market Cap Chart

Since July 25, 1996, Novavax's market cap has increased from 22.60M to 752.34M, an increase of 3,228.98%. That is a compound annual growth rate of 12.88%.

History

DateMarket Cap% Change
Jun 27, 2025752.34M-26.87%
Dec 31, 20241.03B129.81%
Dec 29, 2023447.65M-38.98%
Dec 30, 2022733.56M-90.82%
Dec 31, 20217.99B167.41%
Dec 31, 20202.99B4,139.68%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 158.54B
Shell 158.05B
HSBC Holdings 151.89B
Unilever 115.05B
British American Tobacco p.l.c. 75.07B
Rolls-Royce Holdings 74.43B
Rio Tinto Group 72.20B
RELX PLC 72.14B
Market Cap Rankings